Shire To Buy FerroKin BioSciences
Shire plc (NASDAQ:SHPGY) recently entered into an agreement to acquire FerroKin BioSciences, Inc. As per the terms of the agreement, Shire will make an upfront payment of $100 million and up to $225 million as regulatory, development and commercial milestones upon the achievement of certain pre-specified conditions. FBS0701, the lead pipeline candidate at FerroKin, is [...]
Shire plc (NASDAQ:SHPGY) recently entered into an agreement to acquire FerroKin BioSciences, Inc. As per the terms of the agreement, Shire will make an upfront payment of $100 million and up to $225 million as regulatory, development and commercial milestones upon the achievement of certain pre-specified conditions.
FBS0701, the lead pipeline candidate at FerroKin, is a once-daily oral treatment currently in phase II studies for patients with transfusional iron overload. The presence of surplus iron … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards